Also Included In: Clinical Trials / Drug Trials
Article Date: 04 Aug 2013 - 10:00 PDT Current ratings for:
Potential new drug for tuberculosis
A new drug capable of inhibiting growth of Mycobacterium tuberculosis is reported this week in Nature Medicine. The findings may improve therapeutic options for the treatment of drug resistant tuberculosis (TB).
One-third of the world's population is latently infected with M. tuberculosis and more than a million people die of TB each year. Multidrug-resistant strains of M. tuberculosis are spreading, and therefore the need to develop new and improved drugs is urgent.
Kevin Pethe and colleagues screened a chemical library for inhibitors of M. tuberculosis growth in macrophages and identified imidazopyrimidine amides as potential candidates. The team then optimized these chemicals in order to generate the compound Q203. This compound, which showed efficacy in vitro and in a mouse model of established TB, targets part of the M. tuberculosis electron chain and therefore inhibits ATP synthesis - which is needed for cellular energy production.
The findings support the concept of targeting ATP synthesis to potentially eradicate both active and latent M. tuberculosis and provide a new candidate for clinical validation.
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.Visit our tuberculosis section for the latest news on this subject. Please use one of the following formats to cite this article in your essay, paper or report:
MLA
5 Aug. 2013.
Please note: If no author information is provided, the source is cited instead.
'Potential new drug for tuberculosis'
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
No comments:
Post a Comment